Medicare Enrolled

Dr. Vinod Pullarkat, M.D.

Hematology · Duarte, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1500 DUARTE RD, Duarte, CA 91010
6262564673
In practice since 2006 (19 years)
NPI: 1164433645 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pullarkat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pullarkat? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pullarkat

Dr. Vinod Pullarkat is a hematology specialist in Duarte, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pullarkat performed 577 Medicare services across 169 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pullarkat received a total of $562,465 from 40 pharmaceutical and/or device companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pullarkat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in CA $562,465 industry payments

Medicare Practice Summary

Medicare Utilization ↗
577
Medicare services
Top 42% in CA for hematology
169
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~30 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
387 $80 $256
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
159 $96 $434
New patient office visit, complex (60-74 min) 18 $152 $557
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $46 $167
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$562,465
Total received (2018-2024)
Avg $80,352/year across 7 years
Top 5% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
582
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341,899 (60.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$217,603 (38.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,962 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$105,032
2023
$75,851
2022
$85,754
2021
$84,659
2020
$43,916
2019
$88,778
2018
$78,475

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$30,874
JAZZ PHARMACEUTICALS INC.
$19,438
GENZYME CORPORATION
$15,284
Novartis Pharmaceuticals Corporation
$11,625
Rigel Pharmaceuticals, Inc.
$11,538
SOBI, INC
$4,744
SERVIER PHARMACEUTICALS LLC
$4,307
ABBVIE INC.
$3,628
Pharmacosmos Therapeutics Inc.
$2,943
PFIZER INC.
$219
Astellas Pharma US Inc
$154
Incyte Corporation
$124
Daiichi Sankyo Inc.
$57
Merck Sharp & Dohme LLC
$44
Celgene Corporation
$27
Amgen Inc.
$25
Top 3 companies account for 62.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$73,486
JAZZ PHARMACEUTICALS INC.
$69,228
Amgen Inc.
$66,386
AbbVie, Inc.
$35,959
Alexion Pharmaceuticals, Inc.
$31,615
NOVARTIS PHARMACEUTICALS CORPORATION
$31,460
ABBVIE INC.
$25,719
AbbVie Inc.
$23,417
Servier Pharmaceuticals LLC
$22,796
Dova Pharmaceuticals
$20,547
SOBI, INC
$19,440
Jazz Pharmaceuticals Inc.
$18,598
GENZYME CORPORATION
$18,353
Rigel Pharmaceuticals, Inc.
$17,751
Sobi, Inc
$15,128
Celgene Corporation
$11,298
PFIZER INC.
$9,929
E.R. Squibb & Sons, L.L.C.
$9,607
SERVIER PHARMACEUTICALS LLC
$7,929
Acceleron Pharma, Inc.
$6,819
Genentech USA, Inc.
$6,431
Blueprint Medicines Corporation
$5,780
Pharmacyclics LLC, An AbbVie Company
$3,289
Pharmacosmos Therapeutics Inc.
$2,943
ARGENX US, INC.
$2,800
Agios Pharmaceuticals, Inc.
$2,800
Shire North American Group Inc
$948
Gilead Sciences, Inc.
$488
AstraZeneca Pharmaceuticals LP
$469
Incyte Corporation
$192
Janssen Biotech, Inc.
$190
Astellas Pharma US Inc
$154
Seattle Genetics, Inc.
$127
BioCryst US Sales Co., LLC
$103
SANOFI-AVENTIS U.S. LLC
$89
Daiichi Sankyo Inc.
$77
Merck Sharp & Dohme LLC
$61
Genentech, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$20
Seagen Inc.
$15
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ASPARLAS · Aliqopa · BESPONSA · BOSULIF · Blincyto · CALQUENCE · CRIZANLIZUMAB · DARZALEX · DEFITELIO · DOPTELET · Defitelio · Doptelet · ELITEK · ENJAYMO · Fabhalta · IMBRUVICA · Imbruvica · Inrebic · JADENU · JAKAFI · KYMRIAH · MONOFERRIC · Nplate · ONCASPAR · PREVYMIS · PROMACTA · REBLOZYL · RYLAZE · Reblozyl · Revlimid · Rezlidhia · SCEMBLIX · Soliris · TASIGNA · TIBSOVO · Tibsovo · ULTOMIRIS · Ultomiris · VENCLEXTA · VYVGART · VYXEOS · Vanflyta · Venclexta · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (61%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for hematology in CA.

Looking for a hematology specialist in Duarte?
Compare hematologists in the Duarte area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
38
Per 100K population
0.4
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - BALDWIN PARK
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pullarkat is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pullarkat experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pullarkat performed 387 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pullarkat receive payments from pharmaceutical companies?
Yes. Dr. Pullarkat received a total of $562,465 from 40 companies across 582 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pullarkat's costs compare to other hematologists in Duarte?
Dr. Pullarkat's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pullarkat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →